U.S. Physical Therapy, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US90337L1089
USD
76.30
0.89 (1.18%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Azenta, Inc.
Lifestance Health Group, Inc.
Amedisys, Inc.
The Ensign Group, Inc.
Option Care Health, Inc.
RadNet, Inc.
Teladoc Health, Inc.
U.S. Physical Therapy, Inc.
Guardant Health, Inc.
NeoGenomics, Inc.
Ginkgo Bioworks Holdings, Inc.
Why is U.S. Physical Therapy, Inc. ?
1
High Management Efficiency with a high ROE of 16.16%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.36 times
3
Poor long term growth as Net Sales has grown by an annual rate of 10.85% and Operating profit at 7.40% over the last 5 years
4
The company has declared Positive results for the last 4 consecutive quarters
  • ROCE(HY) Highest at 7.02%
  • DIVIDEND PER SHARE(HY) Highest at USD 8.6
  • NET SALES(Q) Highest at USD 197.34 MM
5
With ROE of 9.58%, it has a expensive valuation with a 2.70 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -23.82%, its profits have fallen by -15.9%
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -23.82% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to U.S. Physical Therapy, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is U.S. Physical Therapy, Inc. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
U.S. Physical Therapy, Inc.
-23.63%
-0.62
34.30%
S&P 500
13.22%
0.64
20.20%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.85%
EBIT Growth (5y)
7.40%
EBIT to Interest (avg)
25.07
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.34
Sales to Capital Employed (avg)
0.96
Tax Ratio
24.42%
Dividend Payout Ratio
95.62%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
14.64%
ROE (avg)
16.16%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
28
Industry P/E
Price to Book Value
2.70
EV to EBIT
22.62
EV to EBITDA
17.32
EV to Capital Employed
2.27
EV to Sales
2.16
PEG Ratio
NA
Dividend Yield
198.40%
ROCE (Latest)
10.06%
ROE (Latest)
9.58%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

17What is working for the Company
ROCE(HY)

Highest at 7.02%

DIVIDEND PER SHARE(HY)

Highest at USD 8.6

NET SALES(Q)

Highest at USD 197.34 MM

INTEREST COVERAGE RATIO(Q)

Highest at 1,263.17

RAW MATERIAL COST(Y)

Fallen by -2.79% (YoY

NET PROFIT(9M)

Higher at USD 23.98 MM

DEBTORS TURNOVER RATIO(HY)

Highest at 8.6 times

OPERATING PROFIT(Q)

Highest at USD 30.59 MM

OPERATING PROFIT MARGIN(Q)

Highest at 15.5 %

PRE-TAX PROFIT(Q)

Highest at USD 22.59 MM

-3What is not working for the Company
DEBT-EQUITY RATIO (HY)

Highest at 54.18 %

INTEREST(Q)

Highest at USD 2.42 MM

Here's what is working for U.S. Physical Therapy, Inc.
Net Profit
At USD 23.98 MM has Grown at 112.77%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (USD MM)

Net Sales
Highest at USD 197.34 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Interest Coverage Ratio
Highest at 1,263.17
in the last five periods
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Dividend per share
Highest at USD 8.6 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

Operating Profit
Highest at USD 30.59 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Operating Profit Margin
Highest at 15.5 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at USD 22.59 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Debtors Turnover Ratio
Highest at 8.6 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Net Profit
Higher at USD 23.98 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months

Net Profit (USD MM)

Raw Material Cost
Fallen by -2.79% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at USD 6.06 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for U.S. Physical Therapy, Inc.
Debt-Equity Ratio
Highest at 54.18 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest
Highest at USD 2.42 MM
in the last five periods and Increased by 6.27% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)